Journal
CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume 100, Issue 5, Pages 464-478Publisher
WILEY
DOI: 10.1002/cpt.436
Keywords
-
Categories
Funding
- National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health [UH3 TR000504]
- NIEHS [5P30ES070033]
- U.S. Environmental Protection Agency [83573801]
Ask authors/readers for more resources
Because of complex cellular microenvironments of both the liver and kidneys, accurate modeling of transport function has remained a challenge, leaving a dire need for models that can faithfully recapitulate both the architecture and cell-cell interactions observed in vivo. The study of hepatic and renal transport function is a fundamental component of understanding the metabolic fate of drugs and xenobiotics; however, there are few in vitro systems conducive for these types of studies. For both the hepatic and renal systems, we provide an overview of the location and function of the most significant phase I/II/III (transporter) of enzymes, and then review current in vitro systems for the suitability of a transporter function study and provide details on microphysiological systems that lead the field in these investigations. Microphysiological modeling of the liver and kidneys using organ-on-a-chip technologies is rapidly advancing in transport function assessment and has emerged as a promising method to evaluate drug and xenobiotic metabolism. Future directions for the field are also discussed along with technical challenges encountered in complex multiple-organs-on-chips development.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available